Rishi Pharmaceuticals, Inc. has developed a capital efficient business strategy that successfully balances scientific and financial risk to develop a pipeline of valuable new therapeutic products. Rishi bridges biological innovative early stage drug discovery in US and European academia and biotechnology companies with cost effective drug development and early stage clinical trials in India.

Rishi is developing a portfolio of valuable clinical products by in-licensing therapeutically validated lead molecules and deploying scientific and clinical resources in India to support its R&D operations. Rishi will achieve its commercial objectives either through internal funding resources or collaborative partnerships with pharmaceutical companies.